After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth. 01022024160133
Executive Insights Life Sciences & Pharma First vs. Best in Class — Simplifying the Equation for Biopharma June 27, 2024
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Video / Webinar Life Sciences & Pharma L.E.K. Look Forward - L.E.K. Talent Focused Organisational Strategy December 13, 2023
Article Life Sciences & Pharma The SEA Healthcare, Medtech, and Pharma Landscape in 2023 December 7, 2023
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023